Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.
Abstract
BACKGROUND: It remains unclear whether hypertriglyceridemia is an independent risk factor for coronary heart disease (CHD), and whether fasting and nonfasting triglyceride (TG) levels are equally predictive. METHODS: A total of 2809 (of 12 866) men randomized during 1973 through 1975 into the Multiple Risk Factor Intervention Trial with fasting and nonfasting TG levels measured at baseline were followed up for CHD incidence and death. Proportional hazards regression models were used to assess associations of fasting and nonfasting TG levels with CHD. RESULTS: Average fasting and nonfasting TG levels were 187 and 284 mg/dL (2.11 and 3.21 mmol/L), respectively. Prevalence of hypertriglyceridemia (200 mg/dL [2.26 mmol/L] or more) was 31% for fasting and 61% for nonfasting. There were 175 nonfatal or fatal CHD events during 8 years and 328 CHD deaths during 25 years. Compared with TG levels less than 200 mg/dL, risk factor-adjusted hazard ratios for CHD mortality for hypertriglyceridemia were 1.24 (P =.09) for fasting and 1.26 (P =.07) for nonfasting. For nonfatal or fatal CHD, fasting and nonfasting TG levels were similarly predictive with hazard ratios of 1.64 (P =.004) for fasting and 1.46 (P =.03) for nonfasting. These associations for fasting TG levels were assessed to be underestimated by 56% because of regression dilution bias, with attenuation likely greater for nonfasting TG levels. CONCLUSIONS: Greater ease of obtaining nonfasting than fasting measurements, greater prevalence of hypertriglyceridemia with nonfasting than fasting values, and similarly increased risk with each indicate that nonfasting TG levels may be more useful than fasting ones for risk stratification.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In MRFIT, average fasting and nonfasting triglyceride levels were similarly predictive for nonfatal or fatal coronary heart disease, with hazard ratios of 1.64 and 1.46.
“Investigators of the Multiple Risk Factor Intervention Trial (MRFIT) concluded that average fasting [187 mg/dl (2.11 mmol/liter)] and nonfasting [284 mg/dl (3.21 mmol/ liter)] triglyceride levels were similarly predictive for nonfatal or fatal coronary heart disease with hazard ratios of 1. 64 and 1.46, respectively (21).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [21]
The increase in the postprandial levels of remnant lipoprotein after meals can cause atherosclerosis.
“Zilversmit et al. proposed that the increase in the postprandial levels of remnant lipoprotein after meals can cause atherosclerosis. Considerable evidence has been accumulated thereafter, and this hypothesis has therefore been established as the disease concept238, 243–245).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [245]
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · see citing works
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · see citing works
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122 · see citing works
Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03540110036029 · Cited by 1,085 · see citing works
International Classification of Diseases, Ninth Revision
National Cancer Institute (2020) · Definitions · doi:10.32388/bd1nux · Cited by 891 · see citing works
Clarke, R., Shipley, M. J., Lewington, S., Youngman, L. D., Collins, R., Marmot, M. G., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 879 · see citing works
Proportional Hazards Tests and Diagnostics Based on Weighted Residuals
Grambsch, P. M., & Therneau, T. M. (1994) · Biometrika · doi:10.2307/2337123 · Cited by 356 · see citing works
Serum Triglycerides and Risk of Coronary Heart Disease among Japanese Men and Women
Iso, H., Naito, Y., Sato, S., Kitamura, A., Okamura, T., Sankai, T., Shimamoto, T., Iida, M., & Komachi, Y. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.5.490 · Cited by 325 · see citing works
Wentworth, D. N., Neaton, J. D., & Rasmussen, W. L. (1983) · American Journal of Public Health · doi:10.2105/ajph.73.11.1270 · Cited by 225 · see citing works
Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.276.11.882 · Cited by 210 · see citing works
Roche, H. M., & Gibney, M. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.232s · Cited by 195 · see citing works
International Classification of Diseases, Tenth Revision
National Cancer Institute (2020) · Definitions · doi:10.32388/h9c9cn · Cited by 161 · see citing works
Harjai, K. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00009 · Cited by 150 · see citing works
Postprandial lipoproteins and atherosclerosis
Kenneth, C.-W. Y. (2001) · Frontiers in bioscience · doi:10.2741/yu · Cited by 145 · see citing works
Sharrett, A. R., Chambless, L. E., HEISS, G. M., Paton, C. C., & Patsch, W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2122 · Cited by 143 · see citing works
Two Different Views of the Relationship of Hypertriglyceridemia to Coronary Heart Disease
Grundy, S. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.1.28 · Cited by 133 · see citing works
Ginsberg, H. N., Jones, J., Blaner, W. S., Thomas, A., Karmally, W., Fields, L., Blood, D. K., & Begg, M. D. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1829 · Cited by 128 · see citing works
Ockene, J. K. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90232-8 · Cited by 103 · see citing works
Mortality After 16 Years for Participants Randomized to the Multiple Risk Factor Intervention Trial
(1996) · Circulation · doi:10.1161/01.cir.94.5.946 · Cited by 87 · see citing works
Do Triglycerides Provide Meaningful Information About Heart Disease Risk?
Avins, A. L., & Neuhaus, J. M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.1937 · Cited by 83 · see citing works
The multiple risk factor intervention trial (MRFIT). I. Historical perspective.
Zukel, W. J., Paul, O., & Schnaper, H. W. (1981) · Preventive Medicine · doi:10.1016/0091-7435(81)90057-8 · Cited by 55 · see citing works
Ginsberg, H. N. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-11-199706010-00012 · Cited by 51 · see citing works
Widdowson, G. M., Kuehneman, M., DuChene, A. G., Hulley, S. B., & Cooper, G. R. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90157-1 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619 · see citing works
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works
Langsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.108.804146 · Cited by 588 · see citing works
O’Keefe, J. H., & Bell, D. S. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.107 · Cited by 538 · see citing works
Mora, S., Rifai, N., Buring, J. E., & Ridker, P. M. (2008) · Circulation · doi:10.1161/circulationaha.108.777334 · Cited by 445 · see citing works
Ginsberg, H. N., & MacCallum, P. R. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00044.x · Cited by 331 · see citing works
D. Kolovou, G., P. Mikhailidis, D., Kovar, J., Lairon, D., G. Nordestgaard, B., Chye Ooi, T., Perez-Martinez, P., Bilianou, H., Anagnostopoulou, K., & Panotopoulos, G. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111795495549 · Cited by 306 · see citing works
Hypertriglyceridemia and its pharmacologic treatment among US adults.
Ford, E. S., Li, C., Zhao, G., Pearson, W. S., & Mokdad, A. H. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.599 · Cited by 214 · see citing works
Schwartz, E. A., Koska, J., Mullin, M. P., Syoufi, I., Schwenke, D. C., & Reaven, P. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.028 · Cited by 173 · see citing works
Remnant Lipoproteins As Strong Key Particles to Atherogenesis
Fujioka, Y., & Ishikawa, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e598 · Cited by 146 · see citing works
Iso, H., Imano, H., Yamagishi, K., Ohira, T., Cui, R., Noda, H., Sato, S., Kiyama, M., Okada, T., Hitsumoto, S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.028 · Cited by 104 · see citing works
Nichols, G. A., Philip, S., Reynolds, K., Granowitz, C. B., & Fazio, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00470 · Cited by 102 · see citing works
Murad, M. H., Hazem, A., Coto-Yglesias, F., Dzyubak, S., Gupta, S., Bancos, I., Lane, M. A., Erwin, P. J., Berglund, L., Elraiyah, T., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-2 · Cited by 87 · see citing works
Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state
White, K. T., Moorthy, M. V., Akinkuolie, A. O., Demler, O., Ridker, P. M., Cook, N. R., & Mora, S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241752 · Cited by 74 · see citing works
Davidson, M. H., Maki, K. C., Bays, H., Carter, R., & Ballantyne, C. M. (2009) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2009.08.001 · Cited by 71 · see citing works
Cartier, L.-J., Collins, C., Lagacé, M., & Douville, P. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.11.007 · Cited by 44 · see citing works
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance
Whyte, M. B., Shojaee-Moradie, F., Sharaf, S. E., Jackson, N. C., Fielding, B., Hovorka, R., Mendis, J., Russell-Jones, D., & Umpleby, A. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01176 · Cited by 32 · see citing works
- Authors
- Eberly, L. E.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Eberly, Lynn E.
- ORCID
- Eberly, Lynn E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2003-05-12
- Volume
- 163
- Issue
- 9
- Pages
- 1077
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2126063322
- Cited by
- 226
- References
- 26
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 3 · 2020: 8 · 2019: 4 · 2018: 10 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 18 · 2013: 11 · 2012: 11
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Minnesota
- National Heart, Lung, and Blood Institute (R01 HL 68140, R01-HL-43232, R01HL068140, R01HL043232)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- triglycerides, hypertriglyceridemia, coronary artery disease, cardiovascular risk stratification, coronary heart disease mortality, regression dilution bias, Multiple Risk Factor Intervention Trial
- MeSH terms
- Adult, Coronary Disease, Fasting, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Triglycerides, Hypertriglyceridemia, Odds Ratio, Randomized Controlled Trials as Topic, Risk Assessment, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review